SK Pharmteco bets big on cell, gene therapy
BARCELONA, Spain -- SK Pharmteco, SK Inc.’s contract bio-manufacturing subsidiary, said the company’s burgeoning cell and gene therapy (CGT) business will become its new growth engine. “We continue to expand our CGT business, and the capacity we are building over the next years will allow us to grow this business,” SK Pharmteco CEO Joerg Ahlgrimm said during a press conference Tuesday held on the sidelines of the Convention on Pharmaceutical Ingredients (CPHI) Worldwide, the world’s largest pharma trade show that kicked off earlier this week in Barcelona, Spain. “The goal is to make the CGT unit generate annual sales of over $10 billion in the next few years.” Kim Yeon-tae, head of the Bio Investment Center of SK Inc., the investment unit of SK Group, admitted that the global CGT market growth has been delayed due to the slowing economy and reduced investments, but he stressed that the market could see a turnaround starting in 2024. For the time being, SK Pharmteco, based in California, said it plans to focus on advancing its manufacturing and technological capabilities to respond promptly to the potential surge in demand. In September, the firm became the largest shareholder of Philadelphia-based CGT contract manufacturer Center for Breakthrough Medicines after a series of investments worth $350 million. Adding to its 2021 acquisition of French viral vector contract manufacturer Yposkesi, the firm has secured its production bases both in Europe and the US. “I believe that combining these two (Yposkesi and CBM) creates an offering which not many CDMOs (contract development and manufacturing organizations) have,” Ahlgrimm said. “Having the CGT manufacturing sites in the two major regions will help the company seek new clients.” CBM, which has testing services for CGT developers, will also allow SK Pharmteco to bring more “complete offers” to pharmaceutical and biotech companies that are looking for a CDMO partner who can develop, test and produce their therapies. While ramping up efforts to upgrade CGT capabilities, SK Pharmteco will continue to expand its CDMO capacity for active pharmaceutical ingredients. Separately, the company recently secured an investment of $500 million in a preinitial public offering round. The CEO said the company will reinvest the money to diversify its business portfolio.
- 最近发表
-
- Jeju's autonomy is model for Western Sahara: Morocco
- Seoul shares open higher on US gains; Israel
- Art Token launches Hangeul
- BIFF expands award categories beyond Asian content to global titles
- Volvo EX30 debuts in Korea
- 'Frasier' returns to TV but you don't need to be a superfan of the original to laugh at its jokes
- [Herald Interview] Singer
- 'No Japan?' Korea swings from extreme rejection to selective embrace
- S. Korea's English proficiency slips 13 notches to 49th
- Hyundai Motor chairman marks 3rd year of record earnings
- 随机阅读
-
- Court clears cabbie in death of passenger who jumped out of moving taxi
- YG's new girl group Babymonster to debut next month
- Big firms' debt
- BIFF expands award categories beyond Asian content to global titles
- China’s AliExpress eyes expansion in Korea
- 김건희 여사, 광주디자인비엔날레 찾아 “문화예술계 육성 의지”
- Jungkook becomes first Korean soloist to log 2 songs in Top 5 of Billboard's Hot 100
- [Photo News] Housing solutions in Asia
- Daily Sports Hankook hopes to help stengthen Korea
- 尹대통령 지지율, 1.1%p 내린 38.9% [알앤써치]
- [Today’s K
- BIFF expands award categories beyond Asian content to global titles
- Seoul reviews scenarios for restoring guard posts in DMZ
- 'Frasier' returns to TV but you don't need to be a superfan of the original to laugh at its jokes
- Seoul shares open higher on US gains; Israel
- 'Frasier' returns to TV but you don't need to be a superfan of the original to laugh at its jokes
- School violence drops, drugs among teens surge: police
- N.SSign to resume album promotion without Doha
- Seoul shares close tad higher ahead of key US jobs data
- 사전투표 D
- 搜索
-
- 友情链接
-
- Congressional panel official stresses space
- [Herald Interview] Korean team wins James Dyson Award with ‘hands
- Ive, aespa, NewJeans, StayC and Kiss of Life join star
- [Up close in Yeouido] Spy
- Seoul subway to hold second strike Nov. 22
- UN committee adopts resolution on N. Korean human rights for 19th straight year
- Seoul shares close higher as US inflation softens
- Hyundai Motor chair wins top UK royal honor
- Food trade agency launches global low
- Container shipping costs for US west coast rise 7 pct in October
- Ruling party to appoint innovation committee members
- Sumi Jo awarded Geumgwan Order, highest honor for artists
- 北 "우간다 이어 홍콩 영사관 폐쇄"…재외공관 철수 행렬 왜
- 김웅 "이준석 사면은 내부총질·해당행위…마녀재판 맞았던 것"
- KGC wins minister's award for IP management
- Architect Dominique Perrault's 'Lightwalk' displayed at French Embassy in Seoul
- Samsung Biologics quarterly sales hit W1tr for first time
- [Photo News] Commemoration for Itaewon tragedy in Gwangju
- Mirae Asset Securities names Kim Mi
- Samsung SDI logs record
- [Coffee Klatch] Unique mugwort tea latte paired with flower cakes, dango
- Hyundai Mobis Q3 net jumps 78% on sales growth of key components
- Korean beef prices, poultry shares soar as cattle disease spreads
- Seoul shares open sharply lower on US losses
- Seoul International Pride Film Festival kicks off on Nov. 2
- 홍준표 "난 죄 지은 것 없다, 인요한 사면 논의 자체가 쪽팔려"
- 윤 대통령, 4박 6일 사우디·카타르 순방 마치고 귀국
- Koreans well equipped to overcome global economic turmoil, says ex
- NiziU wins best pop video at MTV VMAJs